Northern Trust’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
Other funds holding NMTC
Northern Trust's NMTC Position: Q3 2026 in Review
Northern Trust held its NeuroOne Medical Technologies (NMTC) position steady in Q3 2026 at 21,398 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #4335.
Northern Trust first reported a position in NMTC in Q4 2021 and has held it in 20 quarters since. The position peaked at $100K in Q3 2025. 21 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.
- Northern Trust held 21,398 shares of NeuroOne Medical Technologies worth $22K as of Q3 2026.
- Northern Trust left its NeuroOne Medical Technologies share count unchanged in Q3 2026.
- NeuroOne Medical Technologies made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4335 holding.
- Northern Trust first reported a position in NeuroOne Medical Technologies in Q4 2021 and has held it in 20 quarters since.
- Northern Trust's NeuroOne Medical Technologies position peaked at $100K in Q3 2025.
- 21 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.